Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers

Treatment with tumor-infiltrating lymphocytes (TILs) has shown remarkable clinical responses in patients with advanced solid tumors. Although the TIL production process is very robust, the original protocol stems from the early nineties and lacks effective selection for tumor-reactivity and function...

Descripción completa

Detalles Bibliográficos
Autores principales: Tas, Liselotte, Jedema, Inge, Haanen, John B.A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
MELANOMA AND OTHER SKIN NEOPLASMS: Edited by Oliver Bechter and Gil Awada
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894146/
https://www.ncbi.nlm.nih.gov/pubmed/36607824
http://dx.doi.org/10.1097/CCO.0000000000000925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894146/
https://www.ncbi.nlm.nih.gov/pubmed/36607824
http://dx.doi.org/10.1097/CCO.0000000000000925

Ejemplares similares